CASI Pharmaceuticals CASIF
OTC CASIF
$0.12 +0.01 (+9.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Receivables - Other (2021 - 2024)

Updated

CASI Pharmaceuticals' Receivables - Other came in at $587 billion for Q4 2024, compared with -$587,000 a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Receivables - Other (2021 - 2024) Analysis & Trends

Going back to Q4 2021, CASI Pharmaceuticals' Receivables - Other data covers 9 quarters.

  • Receivables - Other carries a four-year compound annual growth rate of 4425.1% (FY2020 to FY2024).
  • Going back by year, Receivables - Other was -$587,000 in FY2023, $60,000 in FY2022 (-59.5%), $148,000 in FY2021 (+5.7%) and $140,000 in FY2020.
  • The Q4 2024 figure represents the highest quarterly Receivables - Other in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CASI Pharmaceuticals 2.47 Mn -18.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 587.00 Bn
Jun 30, 2024 963,000.00
Mar 31, 2024 209,000.00
Dec 31, 2023 -587,000.00
Dec 31, 2022 60,000.00
Sep 30, 2022 60,000.00
Jun 30, 2022 60,000.00
Mar 31, 2022 37,000.00
Dec 31, 2021 148,000.00
API Access

CASI Pharmaceuticals Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=CASIF&period=max&api_key=YOUR_API_KEY